Curavit Clinical Research
Curavit Clinical Research is dedicated to revolutionizing clinical trials through decentralized and virtual methodologies. The company focuses on enhancing patient engagement and diversity in clinical research, leveraging technology to streamline processes and improve outcomes for patients and sponsors alike. Curavit is also committed to harnessing health economic value to support digital therapeutics and improve market access for innovative treatments. With a strong emphasis on inclusivity, Curavit aims to address historical disparities in clinical trial participation, ensuring that diverse populations are represented in research. The company has recently raised over $8 million in Series A funding to expand its capabilities in the growing digital therapeutics market, which is projected to reach $11.2 billion by 2030. Curavit has also launched a Health Economics and Outcomes Research (HEOR) practice to capture evidence of the health economics value of novel digital therapeutics, further enhancing its role in the industry.
Curavit Clinical Research
123 Curavit Lane, Philadelphia, PA 19103
What We Do
Curavit specializes in designing and executing decentralized clinical trials (DCTs) that eliminate the need for multiple physical sites, allowing for remote patient monitoring and data collection.
Curavit offers a comprehensive suite of contract research organization (CRO) services tailored for decentralized clinical trials, including study design, patient recruitment, and regulatory support.
Curavit provides HEOR services to uncover economic insights and determine the therapeutic value of new treatments, ensuring they meet payer requirements for coverage and reimbursement.
The IDEA Toolkit promotes inclusivity, diversity, and equity in clinical trials, helping to optimize enrollment and retention of diverse patient populations.
Curavit conducted a successful decentralized trial for the Sana Device, a virtual reality device aimed at reducing PTSD symptoms, achieving a 76% participant retention rate and gathering real-world evidence for FDA review.
Curavit is managing a hybrid decentralized clinical trial for MedRhythms' MR-001, a neurorehabilitation system designed to improve walking in adults with chronic stroke impairments, focusing on patient engagement and health economics.
Key People
News & Updates
Join Curavit at the Bio International Convention in San Diego, California.
Curavit will participate in the DTA Summit, focusing on advancements in decentralized trials.
Curavit will be present at the DIA Annual Meeting in San Diego, California.
Curavit emphasizes the importance of health economics in demonstrating the value of digital therapeutics to improve market access and patient adoption.
Curavit discusses the impact of the DEPICT Act on diversity in clinical trials and the importance of inclusive research practices.
Curavit's CEO discusses the challenges and opportunities in the digital therapeutics market, emphasizing the need for robust data to secure payer coverage.